Glioblastoma is a formidable brain tumor known for its fast growth and unresponsiveness to standard treatments. Studies are constantly underway to identify new treatment strategies, and recently, a unique biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatment. LCA168 is a protein that is highly expressed in GBM cells c